ATE211483T1 - Verbindungen, die die serotoninerge übertragung beeinflussen; ihre diagnostischen und therapeutischen anwendungen - Google Patents
Verbindungen, die die serotoninerge übertragung beeinflussen; ihre diagnostischen und therapeutischen anwendungenInfo
- Publication number
- ATE211483T1 ATE211483T1 AT94929577T AT94929577T ATE211483T1 AT E211483 T1 ATE211483 T1 AT E211483T1 AT 94929577 T AT94929577 T AT 94929577T AT 94929577 T AT94929577 T AT 94929577T AT E211483 T1 ATE211483 T1 AT E211483T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- peptide
- leu
- diagnostic
- affect
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000005540 biological transmission Effects 0.000 title 1
- 230000002295 serotoninergic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 230000007515 enzymatic degradation Effects 0.000 abstract 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 abstract 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9311804A FR2710916B1 (fr) | 1993-10-04 | 1993-10-04 | Composés de nature peptidique ayant une activité modulatrice de la réponse sérotoninergique; applications diagnostiques et thérapeutiques. |
| FR9407078A FR2721029B1 (fr) | 1994-06-09 | 1994-06-09 | Composés modifiant la transmission sérotoninergique; applications diagnostiques et thérapeutiques. |
| FR9407079A FR2721030B1 (fr) | 1994-06-09 | 1994-06-09 | Composés modifiant la transmission sérotoninergique; applications diagnostiques et thérapeutiques. |
| PCT/FR1994/001158 WO1995009868A1 (fr) | 1993-10-04 | 1994-10-04 | Composes modifiant la transmission serotoninergique; applications diagnostiques et therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE211483T1 true ATE211483T1 (de) | 2002-01-15 |
Family
ID=27252801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94929577T ATE211483T1 (de) | 1993-10-04 | 1994-10-04 | Verbindungen, die die serotoninerge übertragung beeinflussen; ihre diagnostischen und therapeutischen anwendungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6713443B1 (de) |
| EP (1) | EP0722457B1 (de) |
| JP (1) | JPH09503220A (de) |
| KR (1) | KR960704921A (de) |
| AT (1) | ATE211483T1 (de) |
| AU (1) | AU678298B2 (de) |
| CA (1) | CA2173460A1 (de) |
| DE (1) | DE69429582T2 (de) |
| DK (1) | DK0722457T3 (de) |
| ES (1) | ES2170105T3 (de) |
| PT (1) | PT722457E (de) |
| WO (1) | WO1995009868A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6759510B1 (en) | 2000-06-30 | 2004-07-06 | Becton, Dickinson And Company | Peptides for use in culture media |
| TWI411441B (zh) * | 2003-03-18 | 2013-10-11 | Suntory Holdings Ltd | 血管收縮素轉化酶抑制性肽類 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5647895B2 (de) * | 1973-06-08 | 1981-11-12 | ||
| JPS6339237B2 (de) | 1979-04-06 | 1988-08-04 | Karuruberugu Baiotekunorojii Ltd As | |
| US4793986A (en) * | 1987-02-25 | 1988-12-27 | Johnson Matthey, Inc. | Macromolecular platinum antitumor compounds |
| SE8803847A0 (sv) * | 1988-10-27 | 1990-04-28 | Kabigen Ab | Neuromodulerande peptid |
| US5104854A (en) * | 1989-02-01 | 1992-04-14 | Washington University | Antiviral peptides |
| FR2657784A1 (fr) * | 1990-02-05 | 1991-08-09 | Pasteur Institut | Facteur endogene cerebral, procede d'obtention et applications therapeutiques et diagnostiques. |
| JPH0421635A (ja) * | 1990-05-16 | 1992-01-24 | Suntory Ltd | アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物 |
-
1994
- 1994-10-04 EP EP94929577A patent/EP0722457B1/de not_active Expired - Lifetime
- 1994-10-04 US US08/624,618 patent/US6713443B1/en not_active Expired - Fee Related
- 1994-10-04 AU AU78579/94A patent/AU678298B2/en not_active Ceased
- 1994-10-04 AT AT94929577T patent/ATE211483T1/de not_active IP Right Cessation
- 1994-10-04 PT PT94929577T patent/PT722457E/pt unknown
- 1994-10-04 JP JP7510646A patent/JPH09503220A/ja active Pending
- 1994-10-04 CA CA002173460A patent/CA2173460A1/fr not_active Abandoned
- 1994-10-04 ES ES94929577T patent/ES2170105T3/es not_active Expired - Lifetime
- 1994-10-04 DK DK94929577T patent/DK0722457T3/da active
- 1994-10-04 KR KR1019960701742A patent/KR960704921A/ko not_active Application Discontinuation
- 1994-10-04 DE DE69429582T patent/DE69429582T2/de not_active Expired - Fee Related
- 1994-10-04 WO PCT/FR1994/001158 patent/WO1995009868A1/fr active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69429582T2 (de) | 2002-08-22 |
| CA2173460A1 (fr) | 1995-04-13 |
| KR960704921A (ko) | 1996-10-09 |
| WO1995009868A1 (fr) | 1995-04-13 |
| DK0722457T3 (da) | 2002-04-22 |
| DE69429582D1 (de) | 2002-02-07 |
| US6713443B1 (en) | 2004-03-30 |
| PT722457E (pt) | 2002-06-28 |
| AU7857994A (en) | 1995-05-01 |
| EP0722457A1 (de) | 1996-07-24 |
| JPH09503220A (ja) | 1997-03-31 |
| AU678298B2 (en) | 1997-05-22 |
| ES2170105T3 (es) | 2002-08-01 |
| EP0722457B1 (de) | 2002-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1571199A3 (de) | Reinigungsmittel enthaltend mehrfach substituierte protease Varianten | |
| CA2173105A1 (en) | Protease-containing cleaning compositions | |
| CA2173973A1 (en) | Subtilisin variants | |
| CA2189426A1 (en) | Subtilisin bpn' variants having decreased adsorption and increased hydrolysis | |
| CA2214348A1 (en) | Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis | |
| CA2193061A1 (en) | Fractionated polydisperse compositions | |
| CA2111645A1 (en) | Fibrinogen fragment e peptides and antibodies thereto | |
| AU2003231471A1 (en) | Antimicrobial polypeptide and utizliation thereof | |
| CA2021379A1 (en) | Pentapeptide antibiotics derived from dalbaheptides | |
| BG104467A (en) | Method for producing 8-methoxy-quinoline carboxylic acids | |
| CA2214579A1 (en) | Subtilisin dy variants having decreased adsorption and increased hydrolysis | |
| EP1006126A3 (de) | Peptide mit osteogener Aktivität | |
| ATE211483T1 (de) | Verbindungen, die die serotoninerge übertragung beeinflussen; ihre diagnostischen und therapeutischen anwendungen | |
| CA2006087A1 (en) | Polypeptides isolated from the venom of the spider hololena curta | |
| DE69722618D1 (en) | Peptide | |
| CA2001265A1 (en) | Analogs of peptidase substrates | |
| AU3850997A (en) | Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines | |
| EP1500700A3 (de) | Pektinsäure-Lyase | |
| CA2203631A1 (en) | Cyclic peptide obtained from actinomyces s. nobilis useful as therapeutic agent | |
| HUP9701290A2 (hu) | Javított tulajdonságú aprotininváltozatok | |
| WO2002085934A3 (fr) | Peptides antibacteriens, les compositions les contenant et leurs utilisations | |
| AU3674889A (en) | Peptide molecules with activity against gram positive microorganisms | |
| AU7209594A (en) | Anti-inflammatory peptides | |
| TH17163A (th) | สารผสมสำหรับทำความสะอาดซึ่งมีโพรทีเอส | |
| TH21704B (th) | เพพไทด์ชนิดใหม่ที่มีผลปรับภูมิคุ้มกัน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |